ViaLase, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
ViaLase, Inc. - overview
Established
2019
Location
Aliso Viejo, CA, US
Primary Industry
Medical Devices & Equipment
About
Based in California, US, and founded in 2019 by CEO Tibor Juhasz, ViaLase, Inc. , a. k. a.
ViaLase, operates as an ophthalmic med-tech company that focuses on designing, developing, and manufacturing femtosecond lasers for ophthalmic surgery for refractive, cataract, and glaucoma patients. In April 2024, ViaLase, Inc. raised USD 40 million in a Series C funding from Venture Investors Health Fund, Arboretum Ventures, Falcon Vision, KKR, and Flying L Partners. The company provides ViaLuxe™ Laser System, along with ViaLens™ Patient Interface, ViaVue™ Gonio Camera, ViaLuxe™ Laser, and ViaLink™ to reduce IOP using femtosecond laser precision and micron-accurate gonio imaging to non-invasively create customized drainage channels through the trabecular meshwork.
The synergy between femtosecond laser technology and gonio imaging delivers visibility and precision, offering doctors detailed, real-time views of tissue structures on a micron scale. ViaLase plans to use its proceeds from April 2024 funding to ensure its focus on advancing its clinical, regulatory, and commercial milestones.
Current Investors
Clarevia Ventures, Arboretum Ventures, Falcon Vision
Primary Industry
Medical Devices & Equipment
Sub Industries
Optometrists & Opticians Products and Services, Surgical Devices, Diagnostic Equipment
Website
www.vialase.com
Verticals
HealthTech, Manufacturing
Company Stage
Series C
Total Amount Raised
Subscriber access only
ViaLase, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.